Display Settings:

Format

Send to:

Choose Destination
Hematol Oncol Clin North Am. 2009 Feb;23(1):35-48, vii. doi: 10.1016/j.hoc.2008.12.001.

Imaging of gastrointestinal stromal tumors and assessment of benefit from systemic therapy.

Author information

  • 1Department of Diagnostic Radiology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA.

Abstract

While gastrointestinal stromal tumors have been increasingly recognized with the prolonged survival and highly effective new targeted treatments, the role of imaging has become important not only for diagnosing and staging the tumors, but also for monitoring the effects of treatment and surveillance. Computed tomography is the imaging modality of choice for these purposes. Fluorine-18 fluorodeoxyglucose positron emission tomography is primarily used in problem solving when there are inconsistencies between CT and clinical findings or inconclusive CT images. The roles of MRI and ultrasound are also described.

PMID:
19248969
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk